glp-1 weight loss clinic rancho cucamonga Injections: Semaglutide and Tirzepatide Medically Supervised GLP-1 Weight Loss

They increase responsiveness of -cells to glucose and to nonglucose secretagogues, resulting in more insulin being released at all blood glucose concentrations

The expanding role of GLP-1 receptor agonists

Important considerations include: Potential interactions with hormonal contraceptives (particularly with tirzepatide and exenatide) Pregnancy planning (GLP-1 medications require discontinuation before conceptiontypically 2 months for semaglutide and 1 month for tirzepatide) Management of gastrointestinal side effects that might overlap with endometriosis symptoms Some hormonal therapies for endometriosis can affect weight, and addressing metabolic health may be a separate but important consideration

Rights and permissions About this article Cite this article Song, G., Yang, D., Wang, Y

10 For instance: The STEP 1 trial , which studied semaglutide (Wegovy) for obesity, used DXA scans (a method to measure body composition) in a subset of participants

Their most common side effects are gastrointestinal symptoms like nausea, vomiting, and constipation